PL1653963T3 - Donosowa kompozycja farmaceutyczna pirybedilu - Google Patents
Donosowa kompozycja farmaceutyczna pirybediluInfo
- Publication number
- PL1653963T3 PL1653963T3 PL04767691T PL04767691T PL1653963T3 PL 1653963 T3 PL1653963 T3 PL 1653963T3 PL 04767691 T PL04767691 T PL 04767691T PL 04767691 T PL04767691 T PL 04767691T PL 1653963 T3 PL1653963 T3 PL 1653963T3
- Authority
- PL
- Poland
- Prior art keywords
- piribedil
- composition
- nasal pharmaceutical
- nasal
- pharmaceutical
- Prior art date
Links
- OQDPVLVUJFGPGQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine Chemical compound C=1C=C2OCOC2=CC=1CN(CC1)CCN1C1=NC=CC=N1 OQDPVLVUJFGPGQ-UHFFFAOYSA-N 0.000 title 1
- 229960004310 piribedil Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0308712A FR2857594B1 (fr) | 2003-07-17 | 2003-07-17 | Composition pharmaceutique pour l'administration par voie nasale de piribedil |
| EP04767691A EP1653963B1 (fr) | 2003-07-17 | 2004-07-16 | Composition pharmaceutique nasale de piribedil |
| PCT/FR2004/001867 WO2005009442A1 (fr) | 2003-07-17 | 2004-07-16 | Composition pharmaceutique pour l’administration par voie nasale de piribedil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1653963T3 true PL1653963T3 (pl) | 2007-02-28 |
Family
ID=33548200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04767691T PL1653963T3 (pl) | 2003-07-17 | 2004-07-16 | Donosowa kompozycja farmaceutyczna pirybedilu |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20060204449A1 (pl) |
| EP (1) | EP1653963B1 (pl) |
| JP (1) | JP2007516947A (pl) |
| KR (1) | KR100807480B1 (pl) |
| CN (1) | CN100540004C (pl) |
| AR (1) | AR046808A1 (pl) |
| AT (1) | ATE349213T1 (pl) |
| AU (1) | AU2004258714A1 (pl) |
| BR (1) | BRPI0412681A (pl) |
| CA (1) | CA2532631C (pl) |
| CY (1) | CY1106013T1 (pl) |
| DE (1) | DE602004003955T2 (pl) |
| DK (1) | DK1653963T3 (pl) |
| EA (1) | EA011041B1 (pl) |
| ES (1) | ES2279435T3 (pl) |
| FR (1) | FR2857594B1 (pl) |
| GE (1) | GEP20074259B (pl) |
| HR (1) | HRP20070081T5 (pl) |
| MA (1) | MA27864A1 (pl) |
| MX (1) | MXPA06000641A (pl) |
| MY (1) | MY137747A (pl) |
| NO (1) | NO332776B1 (pl) |
| NZ (1) | NZ544460A (pl) |
| PL (1) | PL1653963T3 (pl) |
| PT (1) | PT1653963E (pl) |
| SI (1) | SI1653963T1 (pl) |
| UA (1) | UA85193C2 (pl) |
| WO (1) | WO2005009442A1 (pl) |
| ZA (1) | ZA200600240B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009254730B2 (en) * | 2008-06-06 | 2014-06-26 | Pharma Two B Ltd. | Pharmaceutical compositions for treatment of Parkinson's disease |
| WO2014141280A1 (en) * | 2013-03-13 | 2014-09-18 | Abital Pharma Pipelines Ltd. | Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease |
| IT201800005117A1 (it) | 2018-05-07 | 2019-11-07 | Acqua irradiata con energie elettromagnetiche per uso terapeutico |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT689438E (pt) * | 1993-03-26 | 2003-10-31 | Franciscus Wilhelmus He Merkus | Composicoes farmaceuticas para administracao intranasal de apomorfina |
| BE1007402A5 (nl) * | 1993-03-26 | 1995-06-06 | Adir | Nasale farmaceutische preparaten met progestagene stof. |
| FR2710265B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
| FR2710268B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs. |
| FR2742989B1 (fr) * | 1995-12-29 | 1998-01-23 | Adir | Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs |
| JP2001518923A (ja) * | 1997-03-26 | 2001-10-16 | ダブリュ エイチ エム マーカス，フランシスカス | 鼻腔用メラトニン組成物 |
| EP0900567A3 (en) * | 1997-09-05 | 2001-05-02 | Pfizer Products Inc. | Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
| US20020002175A1 (en) * | 2000-09-19 | 2002-01-03 | Charanjit Behl | Nasal delivery of apomorphine in combination with glycol derivatives |
| US20040028613A1 (en) * | 2001-06-25 | 2004-02-12 | Nastech Pharmaceutical Company Inc | Dopamine agonist formulations for enhanced central nervous system delivery |
| FR2827516B1 (fr) * | 2001-07-19 | 2003-09-19 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone |
-
2003
- 2003-07-17 FR FR0308712A patent/FR2857594B1/fr not_active Expired - Fee Related
-
2004
- 2004-07-15 AR ARP040102489A patent/AR046808A1/es unknown
- 2004-07-15 MY MYPI20042838A patent/MY137747A/en unknown
- 2004-07-16 BR BRPI0412681-5A patent/BRPI0412681A/pt not_active IP Right Cessation
- 2004-07-16 PT PT04767691T patent/PT1653963E/pt unknown
- 2004-07-16 ZA ZA200600240A patent/ZA200600240B/en unknown
- 2004-07-16 KR KR1020067001141A patent/KR100807480B1/ko not_active Expired - Fee Related
- 2004-07-16 DE DE602004003955T patent/DE602004003955T2/de not_active Expired - Lifetime
- 2004-07-16 US US10/564,139 patent/US20060204449A1/en not_active Abandoned
- 2004-07-16 PL PL04767691T patent/PL1653963T3/pl unknown
- 2004-07-16 ES ES04767691T patent/ES2279435T3/es not_active Expired - Lifetime
- 2004-07-16 NZ NZ544460A patent/NZ544460A/en not_active IP Right Cessation
- 2004-07-16 HR HR20070081T patent/HRP20070081T5/xx unknown
- 2004-07-16 UA UAA200601630A patent/UA85193C2/ru unknown
- 2004-07-16 EA EA200600172A patent/EA011041B1/ru not_active IP Right Cessation
- 2004-07-16 WO PCT/FR2004/001867 patent/WO2005009442A1/fr not_active Ceased
- 2004-07-16 AT AT04767691T patent/ATE349213T1/de active
- 2004-07-16 AU AU2004258714A patent/AU2004258714A1/en not_active Abandoned
- 2004-07-16 EP EP04767691A patent/EP1653963B1/fr not_active Expired - Lifetime
- 2004-07-16 JP JP2006519966A patent/JP2007516947A/ja active Pending
- 2004-07-16 SI SI200430163T patent/SI1653963T1/sl unknown
- 2004-07-16 CN CNB2004800197495A patent/CN100540004C/zh not_active Expired - Fee Related
- 2004-07-16 MX MXPA06000641A patent/MXPA06000641A/es active IP Right Grant
- 2004-07-16 DK DK04767691T patent/DK1653963T3/da active
- 2004-07-16 GE GEAP20049239A patent/GEP20074259B/en unknown
- 2004-07-16 CA CA2532631A patent/CA2532631C/fr not_active Expired - Fee Related
-
2005
- 2005-12-27 MA MA28688A patent/MA27864A1/fr unknown
-
2006
- 2006-02-16 NO NO20060743A patent/NO332776B1/no not_active IP Right Cessation
-
2007
- 2007-02-13 CY CY20071100190T patent/CY1106013T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2394894B (en) | New use for pharmaceutical composition | |
| AU2003291103A8 (en) | Pharmaceutical composition | |
| IL164547A0 (en) | Pharmaceutical composition | |
| IL176248A0 (en) | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof | |
| HU0301154D0 (en) | Pharmaceutical composition | |
| GB0300427D0 (en) | Pharmaceutical composition | |
| IL165878A0 (en) | Pharmaceutical composition | |
| GB2400565B (en) | Nasal drug delivery | |
| GB0307866D0 (en) | Pharmaceutical composition | |
| GB0304636D0 (en) | Pharmaceutical composition for nasal delivery | |
| EP1699458A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB0329232D0 (en) | Pharmaceutical composition | |
| GB0317663D0 (en) | Pharmaceutical composition | |
| GB0300885D0 (en) | Pharmaceutical composition | |
| EP1600445A4 (en) | CURATIVE PREPARATION | |
| PL1653963T3 (pl) | Donosowa kompozycja farmaceutyczna pirybedilu | |
| GB0306933D0 (en) | Pharmaceutical composition | |
| GB0307869D0 (en) | Pharmaceutical composition | |
| GB0307864D0 (en) | Pharmaceutical composition | |
| GB0307867D0 (en) | Pharmaceutical composition | |
| GB0307862D0 (en) | Pharmaceutical composition | |
| GB0217703D0 (en) | Pharmaceutical composition | |
| GB0307865D0 (en) | Pharmaceutical composition | |
| ZA200403828B (en) | Pharmaceutical composition | |
| GB0330056D0 (en) | Pharmaceutical composition |